AUM Biosciences Pte Ltd.
🇸🇬Singapore
- Country
- 🇸🇬Singapore
- Ownership
- Subsidiary
- Established
- 2018-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer
Phase 2
Recruiting
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2022-07-18
- Last Posted Date
- 2024-07-09
- Lead Sponsor
- AUM Biosciences Pte Ltd
- Target Recruit Count
- 120
- Registration Number
- NCT05462236
- Locations
- 🇦🇺
Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia
🇦🇺Prince of Wales Hospital, Wollongong, New South Wales, Australia
🇦🇺Pindara Private Hospital, Gold Coast Cancer Care, Benowa, Queensland, Australia
News
No news found